Published in Expert Opin Ther Pat on June 26, 2014
The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells. Drug Des Devel Ther (2015) 0.92
MLN8054 and Alisertib (MLN8237): Discovery of Selective Oral Aurora A Inhibitors. ACS Med Chem Lett (2015) 0.86
Aurora kinase targeting in lung cancer reduces KRAS-induced transformation. Mol Cancer (2016) 0.79
A phase I trial of the aurora kinase inhibitor, ENMD-2076, in patients with relapsed or refractory acute myeloid leukemia or chronic myelomonocytic leukemia. Invest New Drugs (2016) 0.77
Multiplex imaging and cellular target identification of kinase inhibitors via an affinity-based proteome profiling approach. Sci Rep (2015) 0.77
Delivery of DNAzyme targeting aurora kinase A to inhibit the proliferation and migration of human prostate cancer. Int J Nanomedicine (2015) 0.76
Allosteric modulation of AURKA kinase activity by a small-molecule inhibitor of its protein-protein interaction with TPX2. Sci Rep (2016) 0.75
Discovery of BPR1K871, a quinazoline based, multi-kinase inhibitor for the treatment of AML and solid tumors: Rational design, synthesis, in vitro and in vivo evaluation. Oncotarget (2016) 0.75
Quercetin suppresses lung cancer growth by targeting Aurora B kinase. Cancer Med (2016) 0.75
In vitro evaluation of a combination treatment involving anticancer agents and an aurora kinase B inhibitor. Oncol Lett (2016) 0.75
The p38 MAPK inhibitor BIRB796 enhances the antitumor effects of VX680 in cervical cancer. Cancer Biol Ther (2016) 0.75
FOXM1 recruits nuclear Aurora kinase A to participate in a positive feedback loop essential for the self-renewal of breast cancer stem cells. Oncogene (2017) 0.75
Involvement of Lgl and Mahjong/VprBP in cell competition. PLoS Biol (2010) 2.45
The hippo pathway promotes Notch signaling in regulation of cell differentiation, proliferation, and oocyte polarity. PLoS One (2008) 1.53
Survivin - biology and potential as a therapeutic target in oncology. Onco Targets Ther (2013) 1.25
Treat cancers by targeting survivin: just a dream or future reality? Cancer Treat Rev (2013) 1.21
Aurora kinase inhibitors in preclinical and clinical testing. Expert Opin Investig Drugs (2009) 1.16
Anti-influenza drug discovery: structure-activity relationship and mechanistic insight into novel angelicin derivatives. J Med Chem (2010) 0.96
Aurora kinase inhibitor patents and agents in clinical testing: an update (2009-10). Expert Opin Ther Pat (2011) 0.96
The microRNA pathway regulates the temporal pattern of Notch signaling in Drosophila follicle cells. Development (2011) 0.94
Synthesis and evaluation of 3-aroylindoles as anticancer agents: metabolite approach. J Med Chem (2009) 0.84
Protein kinase inhibitor design by targeting the Asp-Phe-Gly (DFG) motif: the role of the DFG motif in the design of epidermal growth factor receptor inhibitors. J Med Chem (2013) 0.83
Structural basis for the improved potency of peroxisome proliferator-activated receptor (PPAR) agonists. ChemMedChem (2010) 0.83
Identification of ligand efficient, fragment-like hits from an HTS library: structure-based virtual screening and docking investigations of 2H- and 3H-pyrazolo tautomers for Aurora kinase A selectivity. J Comput Aided Mol Des (2014) 0.83
Notch signaling and developmental cell-cycle arrest in Drosophila polar follicle cells. Mol Biol Cell (2009) 0.82
Reciprocal complementation of the tumoricidal effects of radiation and natural killer cells. PLoS One (2013) 0.82
Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetochore microtubules. Proc Natl Acad Sci U S A (2013) 0.80
Protective effect of Ginkgo biloba leaves extract, EGb761, on endotoxin-induced acute lung injury via a JNK- and Akt-dependent NFκB pathway. J Agric Food Chem (2014) 0.80
Apoptosis induction by an analog of curcumin (BDMC-A) in human laryngeal carcinoma cells through intrinsic and extrinsic pathways. Cell Oncol (Dordr) (2014) 0.80
Generation of ligand-based pharmacophore model and virtual screening for identification of novel tubulin inhibitors with potent anticancer activity. J Med Chem (2009) 0.80
Design and structural analysis of novel pharmacophores for potent and selective peroxisome proliferator-activated receptor gamma agonists. J Med Chem (2009) 0.80
CSN-mediated deneddylation differentially modulates Ci(155) proteolysis to promote Hedgehog signalling responses. Nat Commun (2011) 0.80
BPR1K653, a novel Aurora kinase inhibitor, exhibits potent anti-proliferative activity in MDR1 (P-gp170)-mediated multidrug-resistant cancer cells. PLoS One (2011) 0.80
Scaffold-hopping strategy: synthesis and biological evaluation of 5,6-fused bicyclic heteroaromatics to identify orally bioavailable anticancer agents. J Med Chem (2011) 0.80
Effects of immunotherapy of IL-6 and IL-15 plasmids on transmissible venereal tumor in beagles. Vet Immunol Immunopathol (2009) 0.80
Efficient EGFR signaling and dorsal-ventral axis patterning requires syntaxin dependent Gurken trafficking. Dev Biol (2012) 0.78
Canine CXCL7 and its functional expression in dendritic cells undergoing maturation. Vet Immunol Immunopathol (2009) 0.78
Identification of 11-amino acid peptides that disrupt Notch-mediated processes in Drosophila. J Biomed Sci (2011) 0.78
Analysis of Cell Cycle Switches in Drosophila Oogenesis. Methods Mol Biol (2015) 0.78
Discovery of non-glycoside sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors by ligand-based virtual screening. J Med Chem (2010) 0.78
Recombinant heat shock protein 70 in combination with radiotherapy as a source of tumor antigens to improve dendritic cell immunotherapy. Front Oncol (2012) 0.77
Therapeutic Effect of Yi-Chi-Tsung-Ming-Tang on Amyloid β-Induced Alzheimer's Disease-Like Phenotype via an Increase of Acetylcholine and Decrease of Amyloid β. Evid Based Complement Alternat Med (2012) 0.77
Optimization of ligand and lipophilic efficiency to identify an in vivo active furano-pyrimidine Aurora kinase inhibitor. J Med Chem (2013) 0.77
Canine CD8 T cells showing NK cytotoxic activity express mRNAs for NK cell-associated surface molecules. Vet Immunol Immunopathol (2009) 0.77
3D-QSAR-assisted drug design: identification of a potent quinazoline-based Aurora kinase inhibitor. ChemMedChem (2012) 0.77
Structural Biology Insight for the Design of Sub-type Selective Aurora Kinase Inhibitors. Curr Cancer Drug Targets (2015) 0.76
Anti-influenza drug discovery: identification of an orally bioavailable quinoline derivative through activity- and property-guided lead optimization. ChemMedChem (2012) 0.76
A remotely-controlled locomotive IC driven by electrolytic bubbles and wireless powering. IEEE Trans Biomed Circuits Syst (2015) 0.75
Proneural proteins Achaete and Scute associate with nuclear actin to promote formation of external sensory organs. J Cell Sci (2013) 0.75
Virtual screening of traditional Chinese medicine (TCM) database: identification of fragment-like lead molecules for filariasis target asparaginyl-tRNA synthetase. J Mol Model (2014) 0.75
Urinary nitric oxide metabolite changes in spontaneous and induced onset active labor. Acta Obstet Gynecol Scand (2004) 0.75
Less NO production and better motion parameter in human sperm by swim-up processing. Arch Androl (2004) 0.75
Substituted pyrrolidine-2,4-dicarboxylic acid amides as potent dipeptidyl peptidase IV inhibitors. Bioorg Med Chem Lett (2006) 0.75
Synthesis and structure-activity relationships of 2-amino-1-aroylnaphthalene and 2-hydroxy-1-aroylnaphthalenes as potent antitubulin agents. J Med Chem (2008) 0.75
Physiology-based diagnosis algorithm for arteriovenous fistula stenosis detection. Conf Proc IEEE Eng Med Biol Soc (2014) 0.75
A Smart CMOS Assay SoC for Rapid Blood Screening Test of Risk Prediction. IEEE Trans Biomed Circuits Syst (2016) 0.75